A clinical study of PASylated nomacopan for geographic atrophy (GA) in dry age-related macular degeneration (dAMD)
Latest Information Update: 13 Jul 2023
At a glance
- Drugs Nomacopan (Primary)
- Indications Dry macular degeneration
- Focus Adverse reactions
- 11 Jul 2023 According to an Akari Therapeutics media release, company plans submission of IND for treatment of geographic atrophy (GA) in the first half of 2024 and the start of clinical trials in the second half of 2024.
- 04 Aug 2022 New trial record